French health system approves reimbursement of QIAGEN’s QuantiFERON latent TB test

HILDEN, Germany, and PARIS, June 22, 2017 /PRNewswire/ — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced that France’s Ministry of Health and Social Affairs has approved reimbursement by the national health insurance system for QIAGEN’s QuantiFERON-TB® Gold Plus…

Powered by WPeMatico